GF Fund Management CO. LTD. lifted its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 0.6% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 85,874 shares of the semiconductor company's stock after buying an additional 521 shares during the period. Synopsys comprises 0.9% of GF Fund Management CO. LTD.'s holdings, making the stock its 21st largest position. GF Fund Management CO. LTD. owned approximately 0.06% of Synopsys worth $36,827,000 as of its most recent SEC filing.
Other hedge funds also recently modified their holdings of the company. Ameriflex Group Inc. acquired a new position in Synopsys during the fourth quarter valued at approximately $29,000. Pilgrim Partners Asia Pte Ltd acquired a new stake in shares of Synopsys in the 4th quarter valued at approximately $34,000. Hazlett Burt & Watson Inc. grew its stake in shares of Synopsys by 28.6% in the fourth quarter. Hazlett Burt & Watson Inc. now owns 90 shares of the semiconductor company's stock valued at $44,000 after buying an additional 20 shares in the last quarter. Annis Gardner Whiting Capital Advisors LLC increased its holdings in Synopsys by 50.8% during the fourth quarter. Annis Gardner Whiting Capital Advisors LLC now owns 98 shares of the semiconductor company's stock worth $48,000 after buying an additional 33 shares during the last quarter. Finally, GoalVest Advisory LLC bought a new stake in Synopsys during the first quarter worth $50,000. Institutional investors own 85.47% of the company's stock.
Wall Street Analysts Forecast Growth
Several research analysts have recently weighed in on the stock. Needham & Company LLC restated a "buy" rating and set a $650.00 price objective on shares of Synopsys in a research note on Thursday, May 29th. Rosenblatt Securities reduced their price target on Synopsys from $660.00 to $625.00 and set a "buy" rating for the company in a report on Thursday, May 29th. KeyCorp set a $540.00 price objective on Synopsys in a research note on Tuesday, June 3rd. Piper Sandler reaffirmed an "overweight" rating and issued a $615.00 price objective (down from $653.00) on shares of Synopsys in a research report on Thursday, May 29th. Finally, Stifel Nicolaus set a $550.00 target price on Synopsys in a report on Monday, April 28th. One equities research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $607.14.
View Our Latest Stock Report on SNPS
Synopsys Stock Performance
Shares of Synopsys stock traded up $23.65 during trading on Friday, reaching $546.76. The company's stock had a trading volume of 2,020,024 shares, compared to its average volume of 1,177,053. The company has a quick ratio of 6.85, a current ratio of 7.02 and a debt-to-equity ratio of 1.01. The business's 50-day moving average price is $487.88 and its 200-day moving average price is $477.92. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $624.80. The firm has a market cap of $84.83 billion, a PE ratio of 39.48, a P/E/G ratio of 3.62 and a beta of 1.12.
Synopsys (NASDAQ:SNPS - Get Free Report) last issued its quarterly earnings data on Wednesday, May 28th. The semiconductor company reported $3.67 earnings per share for the quarter, topping the consensus estimate of $3.40 by $0.27. Synopsys had a net margin of 34.77% and a return on equity of 17.09%. The business had revenue of $1.60 billion during the quarter, compared to analysts' expectations of $1.60 billion. During the same quarter in the previous year, the company earned $3.00 EPS. The business's revenue was up 10.3% on a year-over-year basis. Equities analysts forecast that Synopsys, Inc. will post 10.64 earnings per share for the current year.
Insider Buying and Selling
In related news, CFO Shelagh Glaser sold 7,310 shares of the business's stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $485.72, for a total value of $3,550,613.20. Following the completion of the transaction, the chief financial officer owned 15,291 shares of the company's stock, valued at $7,427,144.52. The trade was a 32.34% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CRO Richard S. Mahoney sold 9,010 shares of the company's stock in a transaction dated Wednesday, June 18th. The stock was sold at an average price of $471.21, for a total transaction of $4,245,602.10. Following the sale, the executive directly owned 1,485 shares of the company's stock, valued at $699,746.85. This represents a 85.85% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 27,686 shares of company stock valued at $13,001,048 over the last 90 days. 0.62% of the stock is owned by corporate insiders.
Synopsys Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Articles

Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.